CrushSCI.com
109.5平均天数
102中位天数
27最短天数
309最长天数
1502025发文量

Paper Review Records

全部论文审稿周期

21 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

138 天

From anti-drug antibody incidence to clinical relevance: interpreting highly sensitive immunogenicity assays in biosimilars

作者
Anita Krishnan; Somesh BP; Gaurav Mehta; Shilpa Ramaswamy; Soumen Chakraborty; Shyamapada Mandal展开收起
作者单位
1. Biocon Biologics展开收起
PDF源文件 DOI 网页
91 天

From analytical similarity to clinical confidence: how regulatory evolution ensures comparable immunogenicity in streamlined biosimilar development

作者
Sandra Ribes; Marc Rosenbaum; Laura Hartmann; Lisa Allmannsberger; Johann Poetzl展开收起
作者单位
1. Hexal AG (a Sandoz company)展开收起
PDF源文件 DOI 网页
83 天

A validated bioanalytical LC-MS/MS method for the simultaneous determination of molnupiravir, N-hydroxycytidine, and baricitinib in human plasma

作者
Fatma H. Ghazy; Ramzia I. El-Bagary; Samar H. Fahim; Sally T. Mahmoud展开收起
作者单位
1. Cairo University; 2. School of Pharmacy, New Giza展开收起
PDF源文件 DOI 网页
176 天

Electrochemiluminescence immunoassay for quantifying ZMA001 in human serum: method development, validation, and clinical pharmacokinetic application

作者
Abdul-Azeez A. Lanihun; Oluwatobi T. Arisa; Olivia Poczatek; Yi Zeng; Nam Hoon Kwon; Sunghoon Kim; Sandra Cooper; Jason M. Elinoff; William D. Figg展开收起
作者单位
1. Clinical Pharmacology Laboratory, Clinical Center, National Institutes of Health, Bethesda, MD, USA; 2. Department of Pharmaceutical Sciences, College of Pharmacy, Howard University, Washington, DC, USA; 3. Research Institute, Zymedi Co., Ltd., Incheon, South Korea; 4. Department of Integrative Biotechnology, Interdisciplinary Graduate Program, Yonsei University, Incheon, South Korea; 5. Critical Care Medicine and Pulmonary Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA; 6. Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA; 7. Clinical Pharmacology Program, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA展开收起
PDF源文件 DOI 网页
27 天

Highlights from the 17th Japan Bioanalysis Forum Symposium

作者
Katsutomo Hata; Naohito Yamada; Hiroyuki Shimizu; Tomoko Arakawa; Hitoshi Uchiyama; Miyuki Ugajin; Takeshi Okuzono; Eiichi Shimada; Masanori Nagata; Masayo Hashimoto; Hisanori Hara; Takashi Miyayama; Tamiki Mori; Ken-Ichi Yamamoto展开收起
作者单位
1. Shionogi & Co., Ltd; 2. Tanabe Pharma Corporation; 3. Pfizer R&D Japan G.K; 4. Towa Pharmaceutical Co., Ltd; 5. Takeda Pharmaceutical Co., Ltd; 6. Sekisui Medical Co., Ltd; 7. Ono Pharmaceutical Co., Ltd; 8. Astellas Pharma Inc; 9. Otsuka Pharmaceutical Co., Ltd; 10. B2S Life Sciences LLC; 11. Chugai Pharmaceutical Co., Ltd; 12. Mediford Corporation; 13. Shin Nippon Biomedical Laboratories, Ltd展开收起
PDF源文件 DOI 网页
65 天

Investigating the relationship between relative accuracy and linearity acceptance criteria in bioassay validation for clinical studies

作者
Pietro Piu; Stefano Auddino; Gioele Bernardoni; Emanuele Montomoli; Alessandro Manenti展开收起
作者单位
1. VisMederi S.r.l; 2. University of Siena展开收起
PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。